CXCL12 and breast cancer: ANGPTL2 also strengthened responsiveness of BC cells to chemokine (C‐X‐C motif) ligand 12 (CXCL12) by the upregulation of C‐X‐C motif receptor 4 (CXCR4), thus promoted these cells’ recruitment to bone metastatic sites.35